Audentes Therapeutics, Inc.

/Audentes Therapeutics, Inc.

They are a clinical stage biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases.

Symbol

Last Closing Price
$35.46

Shares
4,099,999

Effective Date
January 25, 2018

Underwriters

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange